Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone and Consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Vanta Bioscience Ltd has notified BSE that a Board meeting is scheduled for May 30, 2026 at 6:00 PM at the company's registered office. The agenda includes consideration and approval of Standalone and Consolidated Audited Financial Results for the half year and full financial year ended March 31, 2026. The Board will also take note of the Statutory Auditors' reports on these results. As a continuation of a prior intimation, the company's Insider Trading Window remains closed for all designated persons from April 1, 2026 until June 1, 2026.
This is a routine pre-results announcement notice. No financial specifics are disclosed. Actual results and any auditor qualifications will be known only after the meeting. The extended trading window closure suggests heightened caution around insider information handling.